What are common biomarkers for sapropterin non response?

What drives non-response to sapropterin?

Sapropterin is a synthetic form of tetrahydrobiopterin (BH4) that lowers phenylalanine levels in responsive PKU patients. Non-responders show little or no phenylalanine drop after a BH4 loading test or trial, typically defined as less than 20-30% reduction. Non-response occurs mainly in classical PKU patients who have two severe PAH mutations and low residual enzyme activity.

How do genetic tests predict who will respond?

Genetic testing of the PAH gene identifies patients with at least one mild mutation linked to residual activity. Patients with two severe mutations, such as R408W or R261Q on both alleles, almost never respond. Residual activity predictions from databases such as BIOPKU show 80-90% accuracy in forecasting response, but overlap between responders and non-responders still exists.

What laboratory values distinguish non-responders?

Laboratory tests during a sapropterin trial help distinguish non-responders. Blood phenylalanine measured at 0, 8, 24, and 48 hours after a single-dose challenge with 20 mg/kg sapropterin shows a consistent drop in responders. Non-responders maintain flat phenylalanine curves. Blood BH4 levels after administration do not distinguish groups; they rise in both.

What happens if a patient shows no phenylalanine drop after 48 hours?

No drop after 48 hours indicates non-response. Extension to a four-week trial at 10-20 mg/kg/day confirms this. No drop in phenylalanine in 48 hours or during the vier-week trial suggests no benefit from lang-term use. No benefit suggests switching to alternative therapies such as pegvaliase or strict diet control.

Can blood pterin profiles identify non responders?

Blood pterin profiles do not reliably identify non-responders.